期刊文献+

右旋糖酐-甲基丙烯酸缩水甘油酯载BMP_2凝胶微球的制备与评价 被引量:3

Preparation and Evaluation of BMP_2 Carrying Gel Microspheres by Dextran-glycidyl Methacrylate
下载PDF
导出
摘要 目的:探讨利用右旋糖酐-甲基丙烯酸缩水甘油酯(DEX-GMA)制备载骨形态发生蛋白2(BMP2)凝胶微球的可行性和制备工艺,并初步探讨其载药、释药特性。方法:以反应温度、DEX-GMA和乳化剂Span-80的加入量和搅拌速率等为考察因素进行正交试验,筛选BMP2-DEX-GMA凝胶微球的最佳制备工艺并对成品性能进行初步检测。结果:经悬浮聚合法可以制备BMP2-DEX-GMA凝胶微球,优选出的制备工艺条件为反应温度30℃、DEX-GMA用量0.6%、Span-80用量0.06%、搅拌速率300r/min,由此制备的BMP2-DEX-GMA凝胶微球形态良好,粒径在20μm~50μm之间,包封率为(78.52±4.34)%,载药量为(10.68±1.34)%,溶胀率为85.9%,稳定性和再分散性良好。结论:该凝胶微球载药系统制备工艺简单,载药量大,可以负载具有生物活性的药物。 OBJRCTIVE:To study the feasibility and the preparation of bone morphogenetic protein-2(BMP 2 )carrying gel microspheres by dextran-glycidyl methacrylate(DEX-GMA)and to make an initial study on the drug-loading and drug releasing function of gel.METHODS:The orthogonal test was conducted with the reaction temperature,the addition of DEX-GMA and Span-80,the stirring speed and so on as investigation factors,the best preparation technics of BMP 2 -DEX-GMA gel microspheres was optimized and the finished products of which were given an initial determination.RE-SULTS:The BMP 2 -DEX-GMA gel microspheres preparation could be made by suspension polymerization,the optimized preparation technics including the reaction temperature was30℃,the addition of DEX-GMA and Span-80were0.6%and0.06%respectively,the stirring speed was300r/min,the BMP 2 -DEX-GMA gel microspheres from the above formulation take good shapes with the particle diameter at20μm~50μm,the envelopment ratio was(78.52±4.34)%,the quantity of drug-loading was(10.68±1.34)%,and the swelling ratio was85.9%,which has a good stability and redispersibility.CON-CLUSION:The preparation technics of gel microspheres drug-loading system is simple and the loading dosage is high,which can be used as a bioactive drugs carrier.
出处 《中国药房》 CAS CSCD 北大核心 2005年第12期892-895,共4页 China Pharmacy
基金 *国家高技术研究发展863计划(2002AA205041) "十五"国家科技攻关计划课题(2004BA720A26) 国家自然科学基金(39870932)
关键词 右旋糖酐 甲基丙烯酸缩水甘油酯 骨形态发生蛋白2 凝胶微球 控释 正交试验设计 制备工艺 Dextran Glycidyl methacrylate Bone morphogenetic protein-2 Gel microspheres Controlled release Or-thogonal test Preparation technology
  • 相关文献

参考文献11

  • 1Holland TA,Tessmar J K,Tabata Y, et al. Transforming growth factor- beta1 release from oligo(poly(ethylene glycol) fumarate) hydrogels in conditions that model the cartilage wound healing environment [J] .J Control Release, 2004,94(1):101.
  • 2陈发明,吴织芬,金岩.生长因子载体及缓释系统的研究进展[J].国外医学(口腔医学分册),2005,32(1):44-46. 被引量:8
  • 3Yamamoto M, Takahashi Y, Tabata Y.Controlled release by biodegradable hydrogels enhances the ectopic bone formation of bone morphogenetic protein[J].Biomaterials, 2003,24(24):4375.
  • 4孙勇,徐丽洒,周海英,张其清.洛莫司汀控释膜药效学实验研究[J].中国药房,2003,14(7):390-392. 被引量:1
  • 5陈发明,吴织芬,金岩,王勤涛,吴红,王国芳,杜岩,黄沙,姜瑜.载rhBMP2凝胶微球控释系统的设计与合成实验[J].实用口腔医学杂志,2005,21(2):174-177. 被引量:10
  • 6Mehvar R .Dextrans for targeted and sustained delivery of therapeutic and imaging agents[J] .J Control Release, 2000,69(1):47.
  • 7Zhang Y, Won CY, Chu CC,Synthesis and characterization of biodegradable hydrogels having both hydrophobic and hydrophilic components with controlled swelling behavior[J].J Polym Sci,Part A: Polym Chem,1999,37:4554.
  • 8Franssen O, Vandervennet L, Roders P, et al. Degradable dextran hydrogels:controlled release of a model protein from cylinders and microspheres[J] .J Control Release, 1999,60(3):211.
  • 9Stenekes RJH, Franssen O, Van Bommel EMG, et al.The preparation of dextran microspheres in anall- aqueous system:effect of the formulation parameters on particle characteristics[J] .Pharm Res, 1998,15(6):557.
  • 10Stenekes RJH, Talsma H, Hennink WE.Formation of dextran hydrogels by crystallization[J] Biomaterials,2001,22(11):1891.

二级参考文献41

  • 1陈发明,吴织芬,金岩.牙周组织工程研究进展[J].中华口腔医学杂志,2004,39(6):520-522. 被引量:19
  • 2Kim PM, Wells PG.Genoprotection by UDP- glucuronosyl - transferase in peroxidase - dependent, reactive oxygen species- mediated micronucleous initiation by the carcinogen 4- (methylnitrosamino) - 1 - (3- pyridyl) - 1 - butanone(NNk) and benzo(a) pyrene[J ]. Cancer Res, 1996, 56:1526.
  • 3Darzynkiewicz Z, Li X,Gong JP .Assays of cell viability:discrimination of cells dying by apoptosis[J] .Methods in Cell Biology, 1994, 41 : 15.
  • 4Skehan P, Storeng R, Scudiero D, et al. New colorimetric cytoyoxicity assay for anticancer- drug screening[J].J Natl Cancer Inst , 1990,82:1107.
  • 5Yan GM, Lin SZ, Irwin RP .Activiation of muscarinic cholinergic receptors blocks apoptosis of cultured cerebellar granule neurons[J ]. Molecular Pharma, 1995,47:248.
  • 6Jalil R,Nixon JR.Experimental study of cisplatin microspheres incorporated in polylactic acid and polyethylene glycol acid on peritoneal carcinomatosis in rats[J ]J Microencapsulation, 1997,13: 245.
  • 7Masayuki Yokoyama,Teruo Okano,Yasuhisa Sakurai,et al .Improved synthesis of adriamycin - conjugated poly (ethylene oxide) - poly( aspartic acid) block copolymer and formation of unimodal micellar structure with controlled amount of physically entrapped adriamycin[J ] .Journal of Controlled Release, 1994,32 : 269.
  • 8Sciadini MF, Dawson JM, Johson KD, et al. J Orthop Res, 1997, 15(6) :844-857.
  • 9Uludag H, Norrie B, Kousinioris N, et aL Bioteehnol Bioeng, 2001, 73 (6) :510-521.
  • 10Saito N, Okata T, Moriuchi H, et al. J Bone Joint Surg Am, 2001, 83-A, Suppl (pt2):S92-S98.

共引文献15

同被引文献17

  • 1Mehvar R. Dextrans for targeted and sustained delivery of therapeutic and imaging agents[J]. J Control Release, 2000, 69(1): 47.
  • 2Cadehe JA, van Luyn MJA, Brouwer LA, et al. In vivo biocompatibility of dextran-based hydrogels[J]. J Biomed Mater Res, 2000, 50(4): 397.
  • 3Franssen O, Vandervennet L, Roders P, et al. Degradable dextran hydrogels: controlled release of a model protein from cylinders and microspheres[J]. J Control Release, 1999, 60(3): 211.
  • 4Stenekes RJH, Franssen O, van Bommel EMG, et al. The preparation of dextran microspheres in anall-aqueous system: effect of the formulation parameters on particle characteristics[J]. Pharm Res, 1998, 15(6): 557.
  • 5Stenekes RJH, Talsma H, Hennink WE. Formation of dextran hydrogels by crystallization[J]. Biomaterials, 2001, 22(11): 1 891.
  • 6Reid RH,Boedeker EC,McQueen CE,et al.Preclinical evaluation of microencapsulated CFA/Ⅱ oral vaccine against enterotoxigenic E.coli.[J].Vaccine,1993,11(2):159.
  • 7Morris W,Steinhoff MC,Russell PK.Potential of polymer microencapsulation technology for vaccine innovation[J].Vaccine,1994,12(1):5.
  • 8Schrier JA, DeLuca PP. Porous Bone Morphogenetic Protein-2 Microspheres: Polymer Binding and in vitro Release[ J ]. AAPS PharmsciTech 2001,2( 3 ) : article 17
  • 9吴梧桐.下一个10年的生物技术与生物制药[J].中国药学杂志,1999,34(1):3-6. 被引量:26
  • 10徐超群,张志荣,何勤,廖工铁.米托蒽醌聚乳酸缓释毫微粒冻干针剂在动物体内的靶向性研究[J].华西药学杂志,2000,15(3):164-166. 被引量:19

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部